Dr. Robert C. Weinschenk, MD

Dr. Weinschenk practices at Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma.

Dr. Weinschenk's NPI, 1639589732, was assigned on April 29, 2014. Dr. Weinschenk graduated from Wake Forest School of Medicine in 2014. Dr. Weinschenk holds Texas license BP10050858.

Dr. Weinschenk's primary practice is Ou Medical Center-the Children's Ho - Rad CT - HOPD, at 1200 Childrens Ave, Oklahoma City, OK 73104.

Dr. Weinschenk's primary practice is Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma. Dr. Weinschenk is also affiliated with OU Health University of Oklahoma Medical Center. The medical group on file is OU Health. Dmand AI also links Dr. Weinschenk to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weinschenk practices, 7 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Weinschenk's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Weinschenk is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dr. Weinschenk is licensed in Texas.

Dmand AI lists arthritis, bursitis, fluid in a joint, hip replacement, joint arthropathy, joint pain, knee injury and knee replacement among the conditions Dr. Weinschenk treats.

CMS data shows 207 Medicare services from Dr. Weinschenk across 5 procedure codes in 2024, for 152 Medicare patients. Medicare paid $30,419 for them.

CMS counts 152 Medicare patients who saw Dr. Weinschenk in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have arthritis, and 75% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Weinschenk's median patient age at 68, with 57% women.

In 2024, Dr. Weinschenk wrote 251 Medicare Part D claims for 70 patients. 99% of them were for generic drugs. CMS names the drug for 185 of them, across 8 drugs with 11 or more claims each, at $2,723 in total drug cost. In 2023, CMS named 113 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Weinschenk for performance year 2024, reported as part of a group. Dr. Weinschenk accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Weinschenk as offering telehealth.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Knee replacement: 1 to 10 procedures (CMS shows small counts as a range)

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Weinschenk, published from 2022 to 2025. 2024 was the busiest year, with 3. The most frequent topics are Bone Neoplasms and Sarcoma. Dr. Weinschenk's most frequent co-authors are Alexandra Kathleen Callan, MD, Valerae O. Lewis, MD and Avneesh Chhabra, MD.

CMS Open Payments shows 42 general payments to Dr. Weinschenk from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Stryker Corporation paid the most, $2,045.

Dr. Weinschenk graduated from Wake Forest School of Medicine in 2014.

Dr. Weinschenk is in network with 22 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.